About this Issue
This issue of CRIA Update is devoted to current controversies in HIV treatment. Dr. Carl Fichtenbaum of Washington University has contributed a timely, state-of-the-art review of the issues of stopping prophylaxis and treatment of opportunistic infections in persons on highly active antiretroviral therapy. Tim Horn, a regular contributing writer, has summarized some of the controversies surrounding drug failure and salvage therapy. In a separate article, Tim addresses the current thinking on immune reconstitution and immune-based therapies. Jill Cadman updates us on the new issues surrounding perinatal transmission of HIV, and the controversial topic of post-exposure prophylaxis is detailed in a balanced article by Mike Barr. To start, CRIA's Medical Director highlights some of the key issues surrounding strategies of antiretroviral therapy.
CRIA co-sponsors monthly educational forums on AIDS research and treatment issues. Upcoming forums:
AdvertisementWednesday, November 11th
Wednesday, October 14th
New Drugs in Development
The Immune System and Long-Term Survival
Wednesday, December 9th
Pediatric / Adolescent Update
The forums are held at 7PM in the Cronin Auditorium, 10th Floor of St. Vincent's Hospital at 11th Street and 7th Avenue, Manhattan.